Wanbury Ltd has informed BSE that Major regulatory changes resulting in continuous and severe price cuts has adversely affected revenues and profitability of Cantabria Pharma S. L., a subsidiary of the Company (Wanbury Ltd). Therefore, Cantabria has filed a 'Pre Insolvency Petition' in the Court of Madrid, Spain.
वैल्यू रिसर्च से पूछें 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
